1916
F. Orsini et al. / Tetrahedron: Asymmetry 16 (2005) 1913–1918
was chromatographed on silica gel (eluting with ethyl-
acetate/n-hexane 2:8) and afforded a-bromoacetyl-2-
oxazolidinone 3 (70%) and starting oxazolidinone (20%).
m), 2.7–2.9 (2H, m), 2.98 (1H, ddd, J = 15.4, 8.8,
4.4 Hz), 3.18 (1H, ddd, J = 15.4, 6.6, 4.9 Hz), 3.25 (2H,
J = 6.2 Hz), 4.02 (1H, ddd, J = 11.1, 11.0, 8.4 Hz), 4.25
(1H, m), 4.83 (1H, d, J = 11.1 Hz), 7.01–7.3 (9H); 13C
NMR (CDCl3): 22.29 (t), 25.89 (t), 29.88 (t), 38.72 (t),
44.20 (d), 61.52 (d), 68.18 (d), 123.62 (d), 126.10 (d),
126.72 (d), 127.02 (d), 127.88 (d), 128.13 (d), 2 · 128.64
(d), 128.68 (d), 134.13 (s), 135.34 (s), 141.90 (s), 155.41
(s), 176.20 (s); MS, m/z (%): 365 (1) (M+), 347 (52)
(M+ÀH2O), 130 (100) (C10H10), 91 (100) (C6H5CH2).
Anal. Calcd for C22H23NO4: C, 72.33; H, 6.30. Found:
C, 72.63; H, 6.38.
4.3.1. N-(a-Bromoacetyl)-(4S,5S)-tetrahydronaphthalene-
(1,2-d)-oxazolidin-2-one 3. Colourless crystals, mp =
126 ꢁC (ethylacetate/n-hexane); [a]D = +272 (c 1,
1
CHCl3); H NMR (CDCl3): d 2.08 (1H, m), 2.40 (1H,
m), 3.02 (1H, ddd, J = 14.3, 9.2, 3.7 Hz), 3.18 (1H,
ddd, J = 14.3, 9.1, 4.0 Hz), 4.10 (1H, ddd, J = 11.2,
11.2, 8.0 Hz), 4.42 (1H, d, J = 12 Hz), 4.86 (1H, d,
J = 12 Hz), 4.88 (1H, d, J = 11.2 Hz), 7.0 (1H, dd,
J = 5.5, 1.8 Hz), 7.15–7.25 (3H). 13C NMR (CDCl3):
22.12 (t), 25.69 (t), 28.43 (t), 61.40 (d), 78.79 (d),
123.21 (d), 126.68 (d), 127.77 (d), 128.52 (d), 133.84
(s), 134.59 (s), 154.70 (s), 169.54 (s); EI MS, m/z (%):
311–309 (19) (M+), 230 (76) (M+ÀBr), 188 (82)
(M+ÀBrCH2CO), 144 (29) (188ÀCO2), 130 (100)
(C10H10). Anal. Calcd for C13H12BrNO3: C, 50.32; H,
3.87. Found: C, 50.26; H, 3.87.
4.4.4. N-[(3R)-3-Hydroxy-4,4-dimethyl-pentanoyl]-(4S,5S)-
tetrahydronaphthalene-(1,2-d)-oxazolidin-2-one 8. Yield
81%, mp = 116–118 ꢁC (ethylacetate/n-hexane); [a]D =
+290.3 (c 0.75, CHCl3); 1H NMR (CDCl3): d 1.02
(9H, s), 2.06 (1H, dddd, J = 11.0, 11.0, 10.8, 4.3 Hz),
2.36 (1H, m), 2.98 (1H, ddd, J = 15.2, 8.7, 4.3 Hz),
3.04 (1H, dd, J = 13.6, 11.1 Hz), 3.15 (1H, ddd, J =
15.2, 10.8, 5.4 Hz), 3.36 (1H, dd, J = 13.6, 3.0 Hz), 3.88
(1H, dd, J = 11.1, 3.0 Hz), 4.03 (1H, ddd, J = 11.0,
10.8, 6.5 Hz), 4.84 (1H, d, J = 10.8 Hz), 7.05–7.15
(4H); 13C NMR (CDCl3): d 22.12 (t), 25.38 (t),
3 · 25.56 (q), 34.89 (s), 39.57 (t), 61.29 (d), 76.59 (d),
78.27 (d), 123.50 (d), 126.58 (d), 127.62 (d), 128.42 (d),
133.96 (s), 135.23 (s), 155.35 (s), 176.63 (s); MS m/z
(%): 299 (1) (M+ÀH2O), 273 (4) (M+ÀCO2), 260 (63)
(M+À(CH3)3C), 216 (32) (M+À(CH3)3CCH(OH)CH2),
130 (100) (C10H10). Anal. Calcd for C18H23NO4: C,
68.14; H, 7.26. Found: C, 68.45; H, 7.28.
4.4. Synthesis of b-hydroxyacyloxazolidinones 6–10
4.4.1. Typical procedure at À78 ꢁC. To a tetrahydrofu-
ran solution of samarium iodide (0.1 M, 1.25 mmol), the
bromoacyloxazolidinone 3 (0.175 g, 0.55 mmol) and the
aldehyde (0.55 mmol) in dry tetrahydrofuran (1 mL)
were added dropwise (30 min) at À78 ꢁC. The resulting
mixture was stirred at À78 ꢁC for 30 min and the colour
of the solution turned from deep blue to yellow.14 A di-
luted HCl solution (0.1 N, 9 mL) was then added and
the aqueous phase was extracted three times with ethyl-
acetate (3 · 5 mL). The combined organic extracts were
washed with water, dried (Na2SO4) and the solvent re-
moved under reduced pressure to afford the crude mate-
rial, which was purified by column chromatography
(SiO2; eluting with ethylacetate/n-hexane).
4.4.5. N-[(3R)-3-Hydroxy-4-ethyl-hexanoyl]-(4S,5S)-tet-
rahydronaphthalene-(1,2-d)-oxazolidin-2-one 9. Yield
60%, mp = 92–93 ꢁC (ethylacetate/n-hexane); [a]D =
1
+309.3 (c 1.1, CHCl3); H NMR (CDCl3): d 1.04 (3H,
d, J = 7.5 Hz), 1.04 (3H, d, J = 7.5 Hz), 1.3–1.6 (5H,
m), 2.05 (1H, dddd, J = 10.0, 10.0, 10.0, 4.0 Hz), 2.35
(2H, m), 2.98 (1H, ddd, J = 15.0, 10.0, 4.0 Hz), 3.15
(1H, dd, J = 15.0, 10.0, 4.4 Hz), 3.15 and 3.25 (2H,
4.4.2. N-[(3R)-3-Hydroxy-4-methyl-pentanoyl]-(4S,5S)-
tetrahydronaphthalene-(1,2-d)-oxazolidin-2-one 6. Yield
81%, colourless crystals, mp = 145–146 ꢁC (ethylacetate/
n-hexane); [a]D = +208.4 (c 1, CHCl3); 1H NMR
(CDCl3): d 1.02 (6H, d, J = 6.5 Hz), 1.81 (1H, mt, J =
6.5 Hz), 2.07 (1H, dddd, J = 11.0, 11.0, 10.8, 3.6 Hz),
2.37 (1H, m), 3.0 (1H, ddd, J = 17.5, 9.1, 3.6 Hz), 3.11
(1H, dd, J = 16.2, 6.0 Hz), 3.16 (1H, ddd, J = 17.5,
10.8, 5.4 Hz), 3.32 (1H, dd, J = 16.2, 2.2 Hz), 3.97 (1H,
m), 4.06 (1H, m), 4.85 (1H, d, J = 11.5), 7.05–7.42
(4H); 13C NMR (CDCl3): 13.44 (q), 17.68 (q), 18.46
(d), 22.06 (t), 25.70 (t), 33.75 (d), 41.43 (t), 73.73 (d),
78.29 (d), 126.53 (d), 126.54 (d), 127.63 (d), 128.46 (d),
133.95 (s), 135.17 (s), 155.33 (s), 176.43 (s); MS m/z
(%): 285 (1) (M+ÀH2O), 260 (10) (M+À(CH3)2CH),
216 (92) (M+À(CH3)2CHCH(OH)CH2), 188 (21)
(216ÀCO), 172 (11) (216ÀCO2), 130 (100) (C10H10).
Anal. Calcd for C17H21NO4: C, 67.33; H, 6.93. Found:
C, 67.63; H, 6.98.
ABX system, JAB = 15.0 Hz, JAX = 5.0 Hz, JBX
=
2.5 Hz), 4.0 (1H, ddd, J = 10.0, 10.0, 6.0 Hz), 4.23
(1H, ddd, J = 10.0, 5.0, 2.5 Hz), 4.83 (1H, d,
J = 10.0 Hz), 7.1–7.3 (4H); 13C NMR: 2 · 11.82 (q),
20.86 (t), 21.32 (t), 21.78 (t), 21.99 (t), 25.48 (t), 46.75
(d), 61.22 (d), 70.12 (d), 78.20 (d), 123.73 (d), 126.76
(d), 127.04 (d), 128.35 (d), 133.99 (s), 135.20 (s),
155.31 (s), 176.45 (s); MS, m/z (%): 313 (5)
(M+ÀH2O), 260 (54) (331ÀCH3CH2CHCH2CH3), 216
(30) (260ÀCH(OH)CH2), 172 (7) (216ÀCO2), 130
(100) (C10H10). Anal. Calcd for C19H25NO4: C, 68.88;
H, 7.55. Found: C, 68.55; H, 7.67.
4.4.6. N-[(3R)-3-Hydroxy-3-phenyl-pentanoyl]-(4S,5S)-tet-
rahydronaphthalene-(1,2-d)-oxazolidin-2-one 10. Yield
60%, mp = 156–157 ꢁC (ethylacetate/n-hexane); [a]D =
1
+284.0 (c 1, CHCl3); H NMR (CDCl3): d 2.05 (1H,
dddd, J = 10.0, 10.0, 10.0, 4.8 Hz), 2.48 (1H, ddd,
J = 15.0, 10.0, 4.8 Hz), 3.15 (1H, ddd, J = 17.5, 10.0,
5.0 Hz), 3.28 (1H, m), 3.48 and 3.55 (2H, ABX system,
JAB = 15.0 Hz, JAX = 9.0 Hz, JBX = 5.0 Hz), 4.02 (1H,
ddd, J = 10.0, 10.0, 5.3 Hz), 4.85 (1H, d, J = 10.0 Hz),
5.35 (1H, dd, J = 9.0, 5.0 Hz), 7.01–7.25 (9H); 13C
4.4.3. N-[(3S)-3-Hydroxy-5-phenyl-pentanoyl]-(4S,5S)-
tetrahydronaphthalene-(1,2-d)-oxazolidin-2-one 7. Yield
68%, colourless crystals, mp = 155–156 ꢁC (ethylacetate/
n-hexane); [a]D = +271.1 (c 1.66, CHCl3); 1H NMR
(CDCl3): d 1.85–1.95 (2H, m), 2.05 (1H, m), 2.4 (1H,